As of Apr 27
| -0.09 / -2.14%|
The 1 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +629.93% increase from the last price of 4.11.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.